Associations between bipolar disorder and metabolic syndrome: A review.

OBJECTIVES To examine the pathophysiologic mechanisms that may link bipolar disorder and metabolic syndrome and to discuss whether the consequences of metabolic syndrome underlie a substantive portion of the premature morbidity and mortality observed in persons with bipolar disorder. DATA SOURCES A MEDLINE search, citing articles from 1966 onward, supplemented by a review of bibliographies, was conducted to identify relevant studies. Bipolar disorder, mood disorder, metabolic syndrome, diabetes, cardiovascular illness, and obesity were used as keywords. Criteria used to select studies included (1) English language, (2) published studies with original data in peer-reviewed journals, and (3) studies that confirmed the nature of the mood disorder examined. RESULTS Ninety-seven studies met criteria and were reviewed for evidence of dysregulation in various physiologic systems. Bipolar disorder and metabolic syndrome share features of hormonal, immunologic, and autonomic nervous system dysregulation. CONCLUSION Lifestyle features may account, in part, for the premature mortality observed in bipolar disorder, but the somatic correlates of the illness may also predispose patients to metabolic syndrome and the consequent increased risk of diseases such as diabetes and vascular disease.

[1]  P. Björntorp.  The associations between obesity, adipose tissue distribution and disease. , 2009, Acta medica Scandinavica. Supplementum.

[2]  D. Kupfer,et al.  Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. , 2005, Bipolar disorders.

[3]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[4]  R. Bergman,et al.  Atypical antipsychotics and glucose homeostasis. , 2005, The Journal of clinical psychiatry.

[5]  D. Casey.  Dyslipidemia and atypical antipsychotic drugs. , 2004, The Journal of clinical psychiatry.

[6]  B. McEwen,et al.  Protection and Damage from Acute and Chronic Stress: Allostasis and Allostatic Overload and Relevance to the Pathophysiology of Psychiatric Disorders , 2004, Annals of the New York Academy of Sciences.

[7]  Joseph Conigliaro,et al.  Burden of general medical conditions among individuals with bipolar disorder. , 2004, Bipolar disorders.

[8]  U. Klumpers,et al.  Cardiovascular risk factors in outpatients with bipolar disorder. , 2004, Pharmacopsychiatry.

[9]  A. Young,et al.  Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder , 2004, British Journal of Psychiatry.

[10]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[11]  F. Holsboer,et al.  Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test , 2003, Neuropsychopharmacology.

[12]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[13]  Yogesh K. Dwivedi,et al.  Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment , 2003, Psychopharmacology.

[14]  A. Steiger,et al.  Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression , 2003, Journal of clinical psychopharmacology.

[15]  Hagit Cohen,et al.  Impaired heart rate variability in euthymic bipolar patients. , 2003, Bipolar disorders.

[16]  R. Carney,et al.  Clinical depression and inflammatory risk markers for coronary heart disease. , 2002, The American journal of cardiology.

[17]  P. Cuijpers,et al.  Excess mortality in depression: a meta-analysis of community studies. , 2002, Journal of affective disorders.

[18]  M. Bauer,et al.  Lithium Augmentation Increases the ACTH and Cortisol Response in the Combined DEX/CRH Test in Unipolar Major Depression , 2002, Neuropsychopharmacology.

[19]  Patricia A. Ganz,et al.  Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors , 2002, Psychosomatic medicine.

[20]  Daniel J Buysse,et al.  Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. , 2002, The Journal of clinical psychiatry.

[21]  W. Regenold,et al.  Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. , 2002, Journal of affective disorders.

[22]  Timothy W. Smith,et al.  Psychosocial influences on the development and course of coronary heart disease: current status and implications for research and practice. , 2002, Journal of consulting and clinical psychology.

[23]  H. Stassen,et al.  Mortality of patients with mood disorders: follow-up over 34-38 years. , 2002, Journal of affective disorders.

[24]  H. Wellens,et al.  Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression , 2002, Psychiatry Research.

[25]  M. Bourassa,et al.  Five-Year Risk of Cardiac Mortality in Relation to Initial Severity and One-Year Changes in Depression Symptoms After Myocardial Infarction , 2002, Circulation.

[26]  T. Suppes,et al.  Correlates of overweight and obesity in 644 patients with bipolar disorder. , 2002, The Journal of clinical psychiatry.

[27]  P. Cervantes,et al.  Circadian secretion of cortisol in bipolar disorder. , 2001, Journal of psychiatry & neuroscience : JPN.

[28]  P. Sparén,et al.  Excess mortality in bipolar and unipolar disorder in Sweden. , 2001, Archives of general psychiatry.

[29]  M. Knip,et al.  Early hormonal changes during valproate or carbamazepine treatment , 2001, Neurology.

[30]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[31]  A K Manatunga,et al.  Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.

[32]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[33]  C. O'connor,et al.  Depression and ischemic heart disease. , 2000, American heart journal.

[34]  M. Fava,et al.  Weight gain and antidepressants. , 2000, The Journal of clinical psychiatry.

[35]  D. Kupfer,et al.  Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. , 2000, Bipolar disorders.

[36]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[37]  B. Meyer,et al.  Social support and self-esteem predict changes in bipolar depression but not mania. , 2000, Journal of affective disorders.

[38]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[39]  P. Björntorp,et al.  The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke , 2000, Journal of internal medicine.

[40]  P. Zimmet,et al.  Etiology of the Metabolic Syndrome: Potential Role of Insulin Resistance, Leptin Resistance, and Other Players , 1999, Annals of the New York Academy of Sciences.

[41]  B. Hansen.  The Metabolic Syndrome X , 1999, Annals of the New York Academy of Sciences.

[42]  J. Rybakowski,et al.  The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. , 1999, Journal of psychiatric research.

[43]  G. Fricchione,et al.  Relation between myocardial infarction, depression, hostility, and death. , 1999, American heart journal.

[44]  R. Donahue,et al.  A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. , 1999, Clinical therapeutics.

[45]  B. Kjellman,et al.  Platelet serotonin functions in untreated major depression , 1999, Psychiatry Research.

[46]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[47]  H. Cohen,et al.  Association of Interleukin‐6 and Other Biologic Variables with Depression in Older People Living in the Community , 1999, Journal of the American Geriatrics Society.

[48]  P. Björntorp,et al.  Blood pressure in relation to obesity, insulin and the hypothalamic‐pituitary‐adrenal axis in Swedish men , 1998, Journal of hypertension.

[49]  P. Björntorp,et al.  The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men , 1998, International Journal of Obesity.

[50]  D. Ford,et al.  Depression is a risk factor for coronary artery disease in men: the precursors study. , 1998, Archives of internal medicine.

[51]  B. Barraclough,et al.  Excess mortality of mental disorder , 1998, British Journal of Psychiatry.

[52]  A. Miller,et al.  Neuroendocrine and immune system interactions in stress and depression. , 1998, The Psychiatric clinics of North America.

[53]  B. Carroll,et al.  Plasma dexamethasone concentration and cortisol response during manic episodes , 1998, Biological Psychiatry.

[54]  M. Knip,et al.  Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy , 1998, Annals of neurology.

[55]  S. Montgomery,et al.  Mirtazapine versus amitriptyline in the long‐term treatment of depression: a double‐blind placebo‐controlled study , 1998, International clinical psychopharmacology.

[56]  R. Kessler,et al.  The epidemiology of DSM-III-R bipolar I disorder in a general population survey , 1997, Psychological Medicine.

[57]  A. Sainsbury,et al.  Glucocorticoids as Counterregulatory Hormones of Leptin: Toward an Understanding of Leptin Resistance , 1997, Diabetes.

[58]  B. Felker,et al.  Mortality and medical comorbidity among psychiatric patients: a review. , 1996, Psychiatric services.

[59]  P. Björntorp.  The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[60]  I. Heuser,et al.  Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I , 1995, Biological Psychiatry.

[61]  F. Holsboer,et al.  Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. , 1995, Neuroendocrinology.

[62]  M. Leboyer,et al.  Association of manic-depressive illness with tyrosine hydroxylase microsatellite marker , 1995, The Lancet.

[63]  S. Weiss,et al.  Lithium and Body Weight Gain , 1995, Pharmacopsychiatry.

[64]  M. Trucco,et al.  The genes influencing the susceptibility to IDDM in humans , 1994, Journal of endocrinological investigation.

[65]  E. Eaker,et al.  Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.

[66]  R. Post,et al.  Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. , 1992, The American journal of psychiatry.

[67]  P. Björntorp,et al.  The effects of cortisol on insulin sensitivity in muscle. , 1992, Acta physiologica Scandinavica.

[68]  R. Troisi,et al.  Relation of Obesity and Diet to Sympathetic Nervous System Activity , 1991, Hypertension.

[69]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[70]  J. Nurnberger,et al.  Concordance between anxiety and autonomic nervous system activity in subjects at genetic risk for affective disorder , 1991, Psychiatry Research.

[71]  H. Meltzer,et al.  Outcome in manic disorders. A naturalistic follow-up study. , 1990, Archives of general psychiatry.

[72]  J. Nurnberger,et al.  Electrodermal activity in young adults at genetic risk for affective disorder. , 1989, Archives of general psychiatry.

[73]  D. Brindley,et al.  Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. , 1989, Clinical science.

[74]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[75]  R. Remick,et al.  Weight gain with antidepressants and lithium. , 1988, Journal of clinical psychopharmacology.

[76]  P. Vestergaard,et al.  Prospective studies on a lithium cohort , 1988, Acta psychiatrica Scandinavica.

[77]  P. Grof,et al.  Drugs and the DST: need for a reappraisal. , 1988, The American journal of psychiatry.

[78]  R. Baumgartner,et al.  Fatness and fat patterns: associations with plasma lipids and blood pressures in adults, 18 to 57 years of age. , 1987, American journal of epidemiology.

[79]  M. Vaeth,et al.  Excess mortality of bipolar and unipolar manic-depressive patients. , 1986, Journal of affective disorders.

[80]  G. Borkan,et al.  Relationship of Fat Distribution to Glucose Tolerance: Results of Computed Tomography in Male Participants of the Normative Aging Study , 1986, Diabetes.

[81]  R. Paffenbarger,et al.  Physical activity, all-cause mortality, and longevity of college alumni. , 1986, The New England journal of medicine.

[82]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[83]  D. Blazer,et al.  The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. , 1984, Archives of general psychiatry.

[84]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[85]  A. Kissebah,et al.  Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. , 1983, The Journal of laboratory and clinical medicine.

[86]  D. Lykken,et al.  Electrodermal activity in euthymic unipolar and bipolar affective disorders. A possible marker for depression. , 1983, Archives of general psychiatry.

[87]  D. Murphy,et al.  High plasma norepinephrine levels in patients with major affective disorder. , 1982, The American journal of psychiatry.

[88]  S. L. Lilliker.  Prevalence of diabetes in a manic-depressive population. , 1980, Comprehensive psychiatry.

[89]  H. Freeman.  Resistance to insulin in mentally disturbed soldiers. , 1946, Archives of neurology and psychiatry.

[90]  B. Malzberg.  MORTALITY AMONG PATIENTS WITH INVOLUTION MELANCHOLIA , 1937 .

[91]  Örnulv Ödegård Oslo.  MORTALITY IN NORWEGIAN MENTAL HOSPITALS FROM 1916 TO 1933 , 1936 .

[92]  R. Rubin.  Pharmacoendocrinology of major depression , 2004, European archives of psychiatry and neurological sciences.

[93]  M. Wichers,et al.  The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. , 2004, Journal of psychiatry & neuroscience : JPN.

[94]  E. Keller,et al.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.

[95]  J. Newcomer,et al.  Glucose-induced increase in memory performance in patients with schizophrenia. , 1999, Schizophrenia bulletin.

[96]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[97]  M. Lane,et al.  Leptin regulates proinflammatory immune responses. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  F. Goodwin,et al.  Understanding manic-depressive illness. , 1998, Archives of general psychiatry.

[99]  G. Reaven.  Banting lecture 1988 , 1997 .

[100]  I. Heuser,et al.  Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. , 1996, The American journal of psychiatry.

[101]  L. Sjöström,et al.  Regional distribution of muscle and fat mass in men--new insight into the risk of abdominal obesity using computed tomography. , 1989, International journal of obesity.

[102]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.